Matthew Kohler to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Matthew Kohler has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.222
-
A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer. Cancer. 2012 Jul 01; 118(13):3283-93.
Score: 0.075
-
Health-related quality of life outcomes of docetaxel/carboplatin combination therapy vs. sequential therapy with docetaxel then carboplatin in patients with relapsed, platinum-sensitive ovarian cancer: results from a randomized clinical trial. Gynecol Oncol. 2011 Dec; 123(3):505-10.
Score: 0.074
-
Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancer. Cancer. 2012 Jan 15; 118(2):386-91.
Score: 0.073